Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome
Clinical trial NCT05726916 · RECRUITING
Trial details
- NCT number
- NCT05726916
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-09
- Primary completion
- 2026-05-09
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.